We are live on
!
Find out more
ANI Pharmaceuticals
ANIP
ANIP
170 hedge funds and large institutions have $499M invested in ANI Pharmaceuticals in 2019 Q4 according to their latest regulatory filings, with 15 funds opening new positions, 65 increasing their positions, 59 reducing their positions, and 28 closing their positions.
New
Increased
Maintained
Reduced
Closed
40% more call options, than puts
Call options by funds: $3.63M | Put options by funds: $2.6M
10% more repeat investments, than reductions
Existing positions increased: 65 | Existing positions reduced: 59
8.53% less ownership
Funds ownership: 75.52% → 67% (-8.5%)
11% less funds holding
Funds holding: 190 → 170 (-20)
25% less capital invested
Capital invested by funds: $664M → $499M (-$165M)
46% less first-time investments, than exits
New positions opened: 15 | Existing positions closed: 28
100% less funds holding in top 10
Funds holding in top 10: 2 → 0 (-2)
Holders
170
Holders Change
-20
Holders Change %
-10.53%
% of All Funds
3.35%
Holding in Top 10
–
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-100%
% of All Funds
–
New
15
Increased
65
Reduced
59
Closed
28
Calls
$3.63M
Puts
$2.6M
Net Calls
+$1.03M
Net Calls Change
+$2.67M
Top Buyers
| 1 |
Invesco
Atlanta,
Georgia
|
+$10.8M |
| 2 |
Arrowstreet Capital
Boston,
Massachusetts
|
+$8.1M |
| 3 |
Goldman Sachs
New York
|
+$3.55M |
| 4 |
QI
QS Investors
New York
|
+$2.31M |
| 5 |
HRCM
Hawk Ridge Capital Management
Los Angeles,
California
|
+$2.24M |
Top Sellers
| 1 |
Nomura Holdings
Tokyo,
Japan
|
-$29.4M |
| 2 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$19.8M |
| 3 |
MP
Mangrove Partners
Greenwich,
Connecticut
|
-$12.1M |
| 4 |
CCM
Consonance Capital Management
New York
|
-$10.4M |
| 5 |
Citigroup
New York
|
-$5.15M |
